Dividend compounder review

BIO-B

Bio-Rad Laboratories Inc · NYSE · US

Healthcare · Medical Devices

Chart Factor Intelligence Back to Screener
Score40.00/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 17.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 19.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 3.5 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 0.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$759.9M
Free Cash Flow$374.6M
FCF Covers DividendUnknown
Debt / Equity0.20
P/E50.5
Revenue Growth 5Y0.3%
Net Margin6.5%
ROE2.5%
Price vs Trend4.6%
3Y Return-18.0%
5Y Return-47.5%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Dividend diary

Activity record

BIO-B dividend review warning Warning · Warning

No usable dividend history found.